Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
about
Venous thromboembolic diseaseHeparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsGuidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismAtomic description of the immune complex involved in heparin-induced thrombocytopeniaSuccessful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case seriesHeparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a childDealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approachFondaparinux-associated heparin-induced thrombocytopeniaParenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesTreatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Critical role for mouse marginal zone B cells in PF4/heparin antibody production.Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failureAtomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).Role of factor xa inhibitors in cancer-associated thrombosis: any new data?Low-molecular-weight heparin and intermittent pneumatic compression for thromboprophylaxis in critical patients.
P2860
Q24631121-61F4C210-8692-405C-8CA0-40545EC23854Q26799395-69E358F3-0EAA-4B31-8C67-A65C1FC74F5DQ28079081-2B52924D-4789-4C19-B211-2DD479819D2CQ30665349-D8E2DF88-6EDC-4D0F-A503-6507D4C20D8EQ33380179-581B1686-D595-4FAD-BECA-616A2A4A85A9Q33384369-1DE3A06C-87BD-4F9B-B0D1-2CAADF3CDC43Q33396243-73B8BFEE-F374-4E31-BBC4-1E96DEB3F459Q33399335-7D2F2520-35A5-42EC-A7CC-EDA2A9632DCCQ33399576-6398FEBE-4FDA-4CBC-B523-BA9035AD9571Q33399580-E4777A5F-E666-46E1-8A5D-2B8D985D1E48Q33406245-5728F18B-9925-4ECA-924A-DFD9B7AB5719Q33414539-71CE9EE9-2510-41B2-A2C5-8AF996944B60Q33430677-AEDF2E20-4250-4D37-A2D1-F5E5CAF1854DQ34052232-4BC4CDF0-8DBE-46C1-8754-15C6CF0E87CCQ36334721-8729FBD5-85CE-4335-A890-B8B6A0A8C57F
P2860
Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@ast
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@en
type
label
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@ast
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@en
prefLabel
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@ast
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@en
P2093
P356
P1476
Fondaparinux-related thrombocy ...... nduced thrombocytopenia (HIT).
@en
P2093
Eugenia Rota
Giovanni Fantino
Mario Bazzan
P304
P356
10.1160/TH07-09-0573
P577
2008-04-01T00:00:00Z